PM Society & IQVIA invite those in pharma to attend this State of the Nation event bringing together key stakeholders across the healthcare and life sciences sector to discuss key issues around population health management and access to medicines.
To support pharma clients better understand policy impacting their NHS customers thereby enabling them to develop strategic partnerships with the NHS to support innovation adoption aimed at improving patient outcomes. From the dynamic of the impact of innovative treatments and pathways on population health, improving the real-world evidence base, to health equity and impactful patient support services in collaboration with the NHS.
The event will be followed by a drinks reception.
If you’re a non-member, please register for a free membership to book –
Sign up
-
1:45 pm
Welcome – Carwyn Jones, Director, PM Society and Angela McFarlane, Vice President, Strategic Planning UK & North Europe, IQVIA
-
2:00 pm
Innovation in the UK data landscape - population health and inequalities, Analogue to Digital – Labour Big Shift
- Chair: Angela McFarlane – Vice President, Strategic Planning – IQVIA
- Richard Stubbs – Chair – National Health Innovation Network
- Raj Jain – Chair – NHS Cheshire and Merseyside ICB
- Debbie Flanagan – Director – Gilead Sciences
-
3:00 pm
Networking break
-
3:30 pm
VPAG Chapter 3: Activating patient access to medicines (Labour: Prescription for Growth)
- Chair: Jim McArdle, Strategy Lead, Patient Support Services, IQVIA
- Richard Price – Value Access, Policy Director – Amgen
- Paul Catchpole – Value Access, Policy Director – ABPI
- Pharmacist TBC
-
4:30 pm
Summary
- Richard Robinson – External Affairs Executive Director – BMS
-
5:00 pm
Networking and Drinks